Gardasil Knowledge
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - 26 |
| Updated: | 6/8/2018 |
| Start Date: | February 1, 2017 |
| End Date: | June 1, 2018 |
Gardasil Anonymous Survey
Human papillomavirus (HPV) is the most common viral genital tract infection. The majority of
women and men who are sexually active will be exposed to a strain or strains of the virus.
While there are hundreds of viral strains, high risk strains are associated cervical and oral
cancers. According to the Centers for Disease Control (CDC), between 2008 and 2012 there were
38,793 deaths attributed to HPV related cancers. Vaccinations were created in an attempt to
prevent infection from the most common high risks strains of HPV. Gardasil/HPV-9 was created
to help prevent HPV related cancers and warts. The HPV-9 vaccine includes protection from 7
strains of HPV associated with 74% of HPV related cancers. While Gardasil was approved and
released in 2006, many men and women have not been vaccinated. A national immunization survey
in 2011 of teens 13-17 years old noted that only 60% of girls and 40% of boys have received
at least one vaccination in the series. While complete vaccination series is recommended, a
recent study found that a single dose of Gardasil when compared to placebo created a higher
level of serum antibodies in uninfected females.
women and men who are sexually active will be exposed to a strain or strains of the virus.
While there are hundreds of viral strains, high risk strains are associated cervical and oral
cancers. According to the Centers for Disease Control (CDC), between 2008 and 2012 there were
38,793 deaths attributed to HPV related cancers. Vaccinations were created in an attempt to
prevent infection from the most common high risks strains of HPV. Gardasil/HPV-9 was created
to help prevent HPV related cancers and warts. The HPV-9 vaccine includes protection from 7
strains of HPV associated with 74% of HPV related cancers. While Gardasil was approved and
released in 2006, many men and women have not been vaccinated. A national immunization survey
in 2011 of teens 13-17 years old noted that only 60% of girls and 40% of boys have received
at least one vaccination in the series. While complete vaccination series is recommended, a
recent study found that a single dose of Gardasil when compared to placebo created a higher
level of serum antibodies in uninfected females.
All patients seen at a single clinic will be offered participation in the anonymous survey.
The survey will ask a series of questions regarding basic demographics, sexual history,
smoking status, and Gardasil vaccine knowledge. The survey will serve as evidence of the
vaccine utility by highlighting patient risk factors for HPV and patient knowledge about the
vaccine series.
The survey will ask a series of questions regarding basic demographics, sexual history,
smoking status, and Gardasil vaccine knowledge. The survey will serve as evidence of the
vaccine utility by highlighting patient risk factors for HPV and patient knowledge about the
vaccine series.
Inclusion Criteria:
- All patients 18-26 will be offered participation
Exclusion Criteria:
- Not meeting the inclusion criteria
We found this trial at
1
site
Click here to add this to my saved trials
